Transperineal laser ablation for treating lower urinary tract symptoms of benign prostatic hyperplasia (IPG798)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 8 January 2025
Vibegron for treating symptoms of overactive bladder syndrome (TA999)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 4 September 2024
Transurethral water-jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG770)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 14 September 2023
Botulinum toxin type A injections into the urethral sphincter for idiopathic chronic non-obstructive urinary retention (IPG766)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 June 2023
GreenLight XPS for treating benign prostatic hyperplasia (MTG74)Product type:GuidanceProgramme:Medical technologies guidancePublished: 29 November 2022
Optilume for treating recurrent bulbar urethral strictures (MTG73)Product type:GuidanceProgramme:Medical technologies guidancePublished: 29 November 2022
Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG737)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 21 September 2022
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG58)Product type:GuidanceProgramme:Medical technologies guidancePublished: 4 May 2021
The PLASMA system for transurethral resection and haemostasis of the prostate (MTG53)Product type:GuidanceProgramme:Medical technologies guidancePublished: 6 January 2021
Axonics sacral neuromodulation system for treating refractory overactive bladder (MTG50)Product type:GuidanceProgramme:Medical technologies guidancePublished: 3 September 2020
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia (MTG49)Product type:GuidanceProgramme:Medical technologies guidancePublished: 24 June 2020
Prostatitis (acute): antimicrobial prescribing (NG110)Product type:GuidanceProgramme:NICE guidelinePublished: 31 October 2018
Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG625)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 21 August 2018
Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG611)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 April 2018
Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention (IPG536)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 November 2015
Lower urinary tract symptoms in men: management (CG97)Product type:GuidanceProgramme:Clinical guidelineLast updated: 3 June 2015Published: 23 May 2010
Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia (IPG475)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 January 2014
Mirabegron for treating symptoms of overactive bladder (TA290)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 June 2013
Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal) (TA273)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 January 2013
Laparoscopic augmentation cystoplasty (including clam cystoplasty) (IPG326)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 16 December 2009
Laparoscopic prostatectomy for benign prostatic obstruction (IPG275)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 November 2008
Sacral nerve stimulation for urge incontinence and urgency-frequency (IPG64)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 June 2004
Holmium laser prostatectomy (IPG17)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 November 2003
Transurethral electrovaporisation of the prostate (IPG14)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 October 2003
Aquablation robotic therapy for lower urinary tract symptoms caused by benign prostatic hyperplasia (MIB315)Product type:AdviceProgramme:Medtech innovation briefingPublished: 31 January 2023
iTind for lower urinary tract symptoms caused by benign prostatic hyperplasia (MIB306)Product type:AdviceProgramme:Medtech innovation briefingPublished: 21 September 2022
PLASMA system with button electrode for electrovaporisation of the prostate (MIB274)Product type:AdviceProgramme:Medtech innovation briefingPublished: 31 August 2021
Optilume for anterior urethral strictures (MIB241)Product type:AdviceProgramme:Medtech innovation briefingPublished: 5 January 2021
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MIB210)Product type:AdviceProgramme:Medtech innovation briefingPublished: 17 March 2020
Memokath-028, 044 and 045 stents for urethral obstruction (MIB123)Product type:AdviceProgramme:Medtech innovation briefingPublished: 2 October 2017
Urethrotech UCD for difficult or failed catheterisation (MIB116)Product type:AdviceProgramme:Medtech innovation briefingPublished: 7 August 2017
BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume (MIB50)Product type:AdviceProgramme:Medtech innovation briefingPublished: 22 January 2016